Macrolide-induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin

被引：156

作者：

Westphal, JF ^{[1
]}

机构：

[1] Etab Publ Sante Alsace Nord, Drug & Therapeut Comm, Unit Geriatr Med, F-67170 Strasbourg, France

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 50卷 / 04期

关键词：

cytochromes P450; drug interactions; macrolides;

D O I：

10.1046/j.1365-2125.2000.00261.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：285 / 295

页数：11

共 88 条

[21]

GASCON MP, 1991, CLIN PHARMACOL THER, V49, P158

[22]

Ghali R, 1993, Ann Vasc Surg, V7, P291, DOI 10.1007/BF02000258

[23] Concomitant digoxin toxicity and warfarin interaction in a patient receiving clarithromycin [J].

Gooderham, MJ ;

Bolli, P ;

Fernandez, PG .

ANNALS OF PHARMACOTHERAPY, 1999, 33 (7-8) :796-799

[24] The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin [J].

Gorski, JC ;

Jones, DR ;

Haehner-Daniels, BD ;

Hamman, MA ;

O'Mara, EM ;

Hall, SD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (02) :133-143

[25] Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences [J].

Greenblatt, DJ ;

von Moltke, LL ;

Harmatz, JS ;

Counihan, M ;

Graf, JA ;

Durol, ALB ;

Mertzanis, P ;

Duan, SX .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (03) :278-285

[26] The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin [J].

Greiner, B ;

Eichelbaum, M ;

Fritz, P ;

Kreichgauer, HP ;

Von Richter, O ;

Zundler, J ;

Kroemer, HK .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :147-153

[27] Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin [J].

Grunden, JW ;

Fisher, KA .

ANNALS OF PHARMACOTHERAPY, 1997, 31 (7-8) :859-863

[28]

GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287

[29] ERYTHROMYCIN ENHANCES THE ABSORPTION OF CYCLOSPORIN [J].

GUPTA, SK ;

BAKRAN, A ;

JOHNSON, RWG ;

ROWLAND, M .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (03) :401-402

[30] BIOAVAILABILITY OF CYCLOSPORINE WITH CONCOMITANT RIFAMPIN ADMINISTRATION IS MARKEDLY LESS THAN PREDICTED BY HEPATIC ENZYME-INDUCTION [J].

HEBERT, MF ;

ROBERTS, JP ;

PRUEKSARITANONT, T ;

BENET, LZ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) :453-457

← 1 2 3 4 5 6 7 8 9 →